Marcin graduated from U of Illinois with PhD & MBA degrees. He is a life science entrepreneur and investor. Medicalgorithmics, where he was the co-founding CEO, was the first Polish company to introduce an FDA-approved cardiac telemetry solution to the US and global markets.
During the last 20 years, he managed over 40 R&D and investment projects with a combined budget of over a quarter billion EUR.
Marcin co-founded and has been the lead investor in an early- stage seed fund (LSI) with a portfolio of 11 innovative life science companies and 2 successful exits.
He was a member of the GLG Institute and participated in theEuropean Commission’s expert panels evaluating the Innovative Medicines Initiative (IMI), the world’s largest public- private partnership (PPP) in pharmaceutical research.